#USA #Redmond #Perimetrics #InnerView #Todd Ames

Perimetrics Appoints Todd Ames as Senior Vice President of Sales

In a significant move to propel its commercial strategy, Perimetrics, a pioneering dental technology firm, has appointed Todd Ames as its Senior Vice President of Sales. This strategic appointment comes after the FDA's historic clearance of InnerView, the first and only system capable of measuring internal mobility in teeth—a critical advancement in the realm of dental diagnostics.

The Role of InnerView

InnerView’s groundbreaking technology allows for the early detection of potential issues relating to tooth integrity, such as cracks and loose restorations. With the pressing need for innovative solutions in dental practice, Perimetrics aims to leverage Ames’ expertise to expand its market presence. Utilizing artificial intelligence for structural diagnostics, InnerView delivers real-time information without the need for radiation, thus prioritizing patient safety and enabling faster, more effective clinical decisions.

Robert Hayman, CEO and Chairman of Perimetrics, emphasized the importance of timely interventions in dental practices, stating, "With the growing demand for early detection and predictive diagnostics, the timing couldn't be more important for our innovative commitment to improving patient care. Todd’s leadership is essential in accelerating the rollout of InnerView to ensure dental practices can offer better solutions before patients experience pain. His understanding of scaling a transformative technology aligns perfectly with our vision."

Todd Ames’ Experience and Vision

Ames brings over 25 years of diverse experience in scaling sales organizations across various sectors, including SaaS, digital manufacturing, and healthcare technology. His previous accomplishments include building effective go-to-market teams, launching operations in high-growth settings, and facilitating the adoption of B2B technology in complex clinical environments.

“I am thrilled to join Perimetrics at this pivotal moment in dental care,” said Ames. “The transition in dentistry towards earlier and more objective insights is underway. InnerView equips practices with an unprecedented tool—the ability to measure internal mobility before any symptoms manifest. It’s a game-changer, and I am eager to help bring this innovation into the hands of clinicians across the nation.”

As he steps into this vital role, Ames will be charged with driving Perimetrics’ commercial expansion strategy through 2026. His responsibilities encompass overseeing field sales efforts, engaging with dental service organizations (DSOs), and promoting the adoption of InnerView in specialized practice areas. By focusing on scaling demand post-FDA clearance, growing the national sales force, and enhancing educational initiatives in collaboration with key opinion leaders (KOLs), Ames aims to position Perimetrics as a leader in dental diagnostics.

The Impact of InnerView

InnerView integrates Quantitative Percussion Diagnostics (QPD®) technology that measures 'internal mobility' in teeth—subtle changes that might denote cracks or loose restorations. This system not only revolutionizes diagnostic processes but is also supported by an impressive backlog of 30 clinical studies and 78 global patents, marking it as the first FDA-cleared device of its kind. While the device quantifies mobility, it does not specifically diagnose or detect conditions like cracks or failing restorations, which alerts clinicians to the need for further examination and care.

With Todd Ames at the helm of sales, Perimetrics is poised to redefine dental diagnostics and enhance patient care through its commitment to innovation and excellence. As the demand for better dental technologies rises, the leadership of Ames could position InnerView as a crucial tool in modern dentistry.

Through these strategic efforts, Perimetrics reaffirms its dedication to improving diagnostic capabilities within dentistry and supporting clinicians nationwide. The future looks promising for both the company and the dental professionals who will soon have access to a profound advancement in their diagnostic arsenal.